Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial ; volume:20 ; number:1 ; day:26 ; month:10 ; year:2022 ; pages:1-10 ; date:12.2022
BMC medicine ; 20, Heft 1 (26.10.2022), 1-10, 12.2022
- Urheber
-
Caramelli, Bruno
Yu, Pai Ching
Cardozo, Francisco A. M.
Magalhães, Iuri R.
Spera, Raphael R.
Amado, Daniel K.
Escalante-Rojas, Maria C.
Gualandro, Danielle M.
Calderaro, Daniela
Tavares, Caio A. M.
Borges-Junior, Flavio A.
Pastana, Adriana F.
Matheus, Mariana G.
Brucki, Sonia M. D.
Rodrigues, Ana Carolina O.
Nitrini, Ricardo
Caramelli, Paulo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-022-02563-2
- URN
-
urn:nbn:de:101:1-2022122409030170074854
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Caramelli, Bruno
- Yu, Pai Ching
- Cardozo, Francisco A. M.
- Magalhães, Iuri R.
- Spera, Raphael R.
- Amado, Daniel K.
- Escalante-Rojas, Maria C.
- Gualandro, Danielle M.
- Calderaro, Daniela
- Tavares, Caio A. M.
- Borges-Junior, Flavio A.
- Pastana, Adriana F.
- Matheus, Mariana G.
- Brucki, Sonia M. D.
- Rodrigues, Ana Carolina O.
- Nitrini, Ricardo
- Caramelli, Paulo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
The use of warfarin in veterans with atrial fibrillation
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin
Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
The use of warfarin in veterans with atrial fibrillation
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin
Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
The use of warfarin in veterans with atrial fibrillation
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin
Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study